Table 2

Primary and Secondary Endpoints

1-Year Occurrence Rate (%)2-Year Occurrence Rate (%)
EndpointCABG (n = 97)PCI (n = 101)CABG (n = 97)PCI (n = 101)HR95% CI
Death or nonfatal MI16.9 (54%)10.6 (63%)18.4 (53%)25.3 (31%)0.890.47–1.71
All-cause death5.0 (62%)8.2 (70%)5.0 (62%)21.0 (33%)0.300.11–0.80
Cardiac death5.0 (62%)4.5 (69%)5.0 (62%)10.8 (32%)0.530.16–1.77
All nonfatal MI13.4 (54%)2.6 (62%)15.0 (53%)6.2 (47%)3.321.07–10.30
 Periprocedural MI4.2 (91%)0.0 (101%)4.2 (91%)0.0 (101%)
 Clinical MI7.8 (58%)2.6 (62%)7.8 (58%)6.2 (47%)
 Silent MI1.4 (73%)0.0 (101%)5.3 (40%)0.0 (101%)
Stroke1.2 (82%)1.0 (100%)1.2 (82%)1.0 (100%)1.030.06–16.49
Repeat revascularization11.3 (56%)11.6 (55%)19.5 (26%)18.9 (31%)0.930.42–2.07
Using universal definition of PCI periprocedural MI
 Death or nonfatal MI16.9 (54%)11.6 (63%)18.4 (53%)32.0 (26%)0.720.39–1.35
 All nonfatal MI13.4 (54%)4.8 (62%)15.0 (53%)16.3 (24%)1.340.58–3.11
  Periprocedural MI4.2 (91%)2.3 (75%)4.2 (91%)10.1 (26%)0.720.20–2.57
  Clinical MI7.8 (58%)2.6 (62%)7.8 (58%)6.2 (47%)1.590.45–5.62
  Silent MI1.4 (73%)0.0 (101%)5.3 (40%)0.0 (101%)
Using universal definition of PCI periprocedural MI and no silent MIs
 Death or nonfatal MI14.7 (54%)11.6 (63%)14.7 (54%)32.0 (26%)0.590.30–1.15
 All nonfatal MI11.2 (54%)4.8 (62%)11.2 (54%)16.3 (24%)1.010.41–2.48
  Periprocedural MI4.2 (91%)2.3 (75%)4.2 (91%)10.1 (26%)0.720.20–2.57
  Clinical MI7.8 (58%)2.6 (62%)7.8 (58%)6.2 (47%)1.590.45–5.62

CI = confidence interval; HR = hazard ratio. All other abbreviations as in Table 1.

  • Number of patients at risk.